Marta Ayala Avila

Title: Marta Ayala Avila: Innovator in Biotechnology

Introduction

Marta Ayala Avila is a prominent inventor based in La Habana, Cuba. She has made significant contributions to the field of biotechnology, particularly in the development of recombinant antibodies. Her work has implications for various medical conditions, showcasing her dedication to advancing healthcare solutions.

Latest Patents

Marta holds 1 patent for her invention titled "Recombinant antibodies to the vascular endothelial growth factor (VEGF) which are obtained by means of mutagenesis of variable regions." This invention reveals human recombinant antibodies that recognize the human Vascular Endothelium Growth Factor A (VEGF-A). These antibodies block the interaction with the VEGFR2 receptor and interfere with its proliferative effect in vitro and pro-angiogenic effect in vivo. The antibodies identify a unique epitope on human VEGF-A, different from any previously reported. They were obtained by combining one immunoglobulin light chain variable region with three heavy chain ones. The antibodies can be employed for the immunotherapy of pathological entities associated with increased vasculature, such as age-related macular degeneration and cancer.

Career Highlights

Marta has worked with notable organizations, including the Centro de Ingeniería Genética y Biotecnología and Biorec S.A. Her experience in these institutions has allowed her to contribute to groundbreaking research and development in biotechnology.

Collaborations

Marta has collaborated with esteemed colleagues such as Humberto Lamdan Ordas and Jorge Victor Gavilondo Cowley. These partnerships have enriched her research and expanded the impact of her innovations.

Conclusion

Marta Ayala Avila is a trailblazer in the field of biotechnology, with her innovative work on recombinant antibodies paving the way for advancements in medical treatments. Her contributions reflect her commitment to improving healthcare through scientific innovation.